Literature DB >> 11771827

Insulin (GIK) improves central mixed and hepatic venous oxygenation in clinical cardiac surgery.

L Lindholm1, A Bengtsson, V Hansdottir, A Westerlind, A Jeppsson.   

Abstract

OBJECTIVE: Insulin is a vasodilating agent and it was hypothesized that insulin (GIK) could improve systemic and regional oxygenation in cardiac surgery with cardiopulmonary bypass (CPB). Two questions were addressed: 1) Does insulin improve central mixed and hepatic venous oxygenation during CPB? and 2) Does this treatment reduce systemic levels of the proinflammatory mediators C3a and IL-6?
DESIGN: Prospective, randomized, controlled study at a university hospital. Thirty patients were included and 16 of these received an infusion of insulin, glucose and potassium (GIK) using an euglycemic clamp technique. The insulin infusion was started during hypothermia, 15 min before rewarming. Blood gases and hemodynamic parameters were measured during hypothermia (before the insulin infusion was started), during rewarming at 35 degrees C, and 30 min after CPB was discontinued. Inflammatory markers were measured: preoperatively, during hypothermia and 2 h after CPB.
RESULTS: GIK was associated with reduced systemic vascular resistance (p = 0.02 vs the control group), higher bypass pump flow (p = 0.001). higher central mixed oxygen saturation (p = 0.036) and oxygen tension (p = 0.001) and higher hepatic venous oxygen saturation (p = 0.04) and oxygen tension (p = 0.006). C3a and IL-6 increased during surgery in both groups but there were no differences between the groups.
CONCLUSION: 1) GIK infusion improved central mixed and hepatic venous oxygenation in patients undergoing heart surgery. 2) During the conditions of this study, this had no effect on the proinflammatory mediators C3a and IL-6.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11771827     DOI: 10.1080/140174301317116334

Source DB:  PubMed          Journal:  Scand Cardiovasc J        ISSN: 1401-7431            Impact factor:   1.589


  2 in total

Review 1.  Effect of perioperative glucose-insulin-potassium infusions on mortality and atrial fibrillation after coronary artery bypass grafting: a systematic review and meta-analysis.

Authors:  Doreen Rabi; Fiona Clement; Finlay McAlister; Sumit Majumdar; Reg Sauve; Jeffrey Johnson; William Ghali
Journal:  Can J Cardiol       Date:  2010 Jun-Jul       Impact factor: 5.223

Review 2.  Effect of glucose-insulin-potassium infusion on mortality in critical care settings: a systematic review and meta-analysis.

Authors:  Michael A Puskarich; Michael S Runyon; Stephen Trzeciak; Jeffrey A Kline; Alan E Jones
Journal:  J Clin Pharmacol       Date:  2009-05-05       Impact factor: 3.126

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.